ArticleImmunology2008

Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.

Edilberto Postól et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.